Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze ALL stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate ALL investment potential.

What is ALL stock price today?

Get real-time ALL stock price, historical data, and price charts on Financhill. Track ALL performance with our advanced analysis tools.

Is ALL a good investment?

Evaluate ALL investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy ALL stock?

To buy ALL stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of ALL?

View detailed market capitalization data and company valuation metrics for ALL on our comprehensive analysis page.

What is the P/E ratio of ALL?

Use our fundamental analysis tools to view ALL P/E ratio and compare valuation metrics with industry peers.

What are ALL earnings?

View ALL earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

The Allstate Corp. 10K Form

Buy

ALL
The Allstate Corp.

Last Price:

$206.37

Seasonality Move:

1.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-02-21	10K	ALL/The Allstate Corp. Annual
2023-11-01	10Q	ALL/The Allstate Corp. Quarterly
2023-08-01	10Q	ALL/The Allstate Corp. Quarterly
2023-05-03	10Q	ALL/The Allstate Corp. Quarterly
2023-02-16	10K	ALL/The Allstate Corp. Annual
2022-11-02	10Q	ALL/The Allstate Corp. Quarterly

Receive ALL News And Ratings

See the #1 stock for the next 7 days that we like better than ALL

ALL Financial Statistics

Sales & Book Value

Annual Sales:	$64.1B
Cash Flow:	$3.2B
Price / Cash Flow:	6.47
Annual Sales:	$97.34
Price / Book:	2.14

Profitability

EPS (TTM):	30.88610
Net Income (TTM):	$8.3B
Gross Margin:	$0
Return on Equity:	35.98%
Return on Assets:	7.83%

The Allstate Corp. Earnings Forecast

Key The Allstate Corp. Financial Ratios

The Gross Profit Margin over the past 33 years for ALL is 0.00%.
The Selling, General & Administrative Expenses for ALL have been equal to 0.00% of Gross Profit Margin.
The Interest Expense is 8.70% of Operating Income.
The Net Earning history of ALL is 7.17% of Total Revenues.
Per Share Earnings over the last 33 years have been positive in 20 years.

The Allstate Corp. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	S&P500
Industry:	Insurance
Sector:	Financials
Current Symbol:	ALL
CUSIP:	020002
Website:	allstate.com

Debt

Debt-to-Equity Ratio:	0.29
Current Ratio:	0.52
Quick Ratio:	0

Price-to-Earnings

Trailing P/E Ratio:	12.28
Forward P/E Ratio:	8.64

ALL Technical Analysis vs Fundamental Analysis

Buy

The Allstate Corp. (ALL) is a Buy

Is The Allstate Corp. a Buy or a Sell?

The Allstate Corp. stock is rated a Buy

The current The Allstate Corp. [ALL] share price is $206.37. The Score for ALL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.